MedPath

Evaluation of the effect of tacrolimus on carbohydrate metabolism in pre-renal transplantation dialysis patients

Phase 1
Conditions
Hemodialysis
Therapeutic area: Phenomena and Processes [G] - Metabolism [G03]
Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Investigative Techniques [E05]
Registration Number
CTIS2024-514072-40-00
Lead Sponsor
Centre Hospitalier Departemental Vendee
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
All
Target Recruitment
20
Inclusion Criteria

= 18 years old, Patient eligible for a kidney transplant at Nantes University Hospital, Hemodialysis patient in one of the participating centers, Patient able to understand the proposed protocol and having given free and informed consent, Patient with social security coverage

Exclusion Criteria

Personal history of treated or untreated diabetes, Patients under guardianship, curatorship, legal protection, or deprived of liberty, Pregnant, breast-feeding or premenopausal women refusing contraception, Temporary contraindication for carcinological reasons, Immunosuppressive treatment in the 6 months prior to inclusion, Macrolide allergies, Hypersensitivity to excipients in the composition of tacrolimus, Intolerance to the HGPO test, Infectious outbreak, Liver failure, Intercurrent infectious pathology

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath